CJC-1295 is a synthetic peptide believed to function as a growth hormone-releasing hormone (GHRH) analog. It is structurally designed to increase the half-life of endogenous growth hormone-releasing ...

Peptides have emerged as a central focus of study in various sectors due to the wide variety of biological actions that they are capable of. CJC-1295 and Ipamorelin, in particular, have garnered much ...

HOUSTON, October 06, 2025--(BUSINESS WIRE)--SynergenX, veteran-owned leader in personalized hormone and wellness medicine, is expanding its peptide therapy program with the addition of BPC-157 and CJC ...

Peptide research has gained substantial momentum in recent years, with an increasing focus on understanding how specific peptide blends might contribute to diverse scientific implications. Peptides ...